Medical News

RSS

WaferGen Biosystems announces closing of $7.2M registered direct offering

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.

9 Jul 2010

U.N. report recommends changes for fragmented global aid system

"A proliferation of aid agencies, donors, and projects is fragmenting the global aid system, increasing transaction costs, and weakening efforts to reduce poverty and poor health," according to the U.N.'s recent World Economic and Social Survey (.pdf), BMJ News reports.

9 Jul 2010

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.

9 Jul 2010

FDA approves Roxane's Naratriptan Tablets ANDA

Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.

9 Jul 2010

Woman sues California Blue Shield for alleged safety-net insurance overcharges

Los Angeles Times: A Los Angeles woman is suing Blue Shield of California for allegedly overcharging policyholders for safety-net insurance for the jobless or sick. "Amalia Lample said in her lawsuit that Blue Shield, the state's second-largest not-for-profit insurer, knowingly exceeded maximum insurance rates set by the state and falsely reported to regulators that the charges stayed within official guidelines.

9 Jul 2010

Roxane announces FDA approval for Anastrozole Tablets ANDA

Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1mg by the U.S. Food and Drug Administration. The product is available in bottles of 30 for immediate shipment to wholesalers and pharmacies nationwide.

9 Jul 2010

VBA acquires BISNet software from ClearBenefits

Vantage Benefits Administrators (VBA) is proud to announce the acquisition of the BISNet software and all its Intellectual Property from ClearBenefits, Inc. to strategically enhance our Unified Point of Service administration offerings. BISNet, Inc., a fully owned subsidiary of Vantage Benefits Administrators, will reemerge as a world class benefits enrollment and administration system provider on July 15, 2010.

9 Jul 2010

Medicare agency releases data on hospital performance

MedPage Today: "The public can now review data on the quality of outpatient care provided by individual hospitals at the Centers for Medicare and Medicaid Services' Hospital Compare website. The site previously contained only data on inpatient care quality. All the data are derived from records of Medicare patients treated at more than 3,600 hospitals nationwide."

9 Jul 2010

iPierian announces closing of $22M Series B equity financing round

iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.

9 Jul 2010

Qualaquin for treatment of night time leg cramps leads to serious side effects, FDA warns

The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.

9 Jul 2010

Officials look to stop 'medicalization' to stem health care costs

The Florida Times-Union: Stopping the "medicalization" of good health is being targeted again by economists and policymakers as a way to stem health care costs. "If Americans would stop thinking of certain problems in a medical context, experts argue, it might chip away at the more than $2 trillion the nation spends annually on health care.

9 Jul 2010

Psychosocial risk factors in children can be identified during transition from preschool to formal schooling

Social competence and behavior problems that are evident at kindergarten and first grade are known to be strong predictors of a child's academic and social functioning. However, findings reported in the July issue of the Journal of the American Academy of Child and Adolescent Psychiatry suggest that psychosocial risk factors can be identified even earlier and can be observed during the transition from preschool to formal schooling.

9 Jul 2010

ITelagen to provide EHR, outsourced billing and IT support for Canterbury Medical Associates

ITelagen, a leading provider of Healthcare IT solutions, was selected by Christ Hospital to provide electronic health records (EHR) as part of an entire back-office solution that includes outsourced billing and unlimited IT support for their affiliate Canterbury Medical Associates.

9 Jul 2010

Hospitals struggle to escape unsuccessful Wall Street wagers

"Hospitals nationwide are tangling with Wall Street to get out of disastrous wagers that have complicated their financial problems," The Wall Street Journal reports.

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

Health Care REIT reports $292.9M of gross investments during second-quarter 2010

Health Care REIT, Inc. announced today that it completed $292.9 million of gross investments during the second quarter of 2010. During the quarter, the company had dispositions of $14.6 million, resulting in net new investments of $278.3 million. For the six months ended June 30, 2010, the company completed $877.6 million of gross investments, offset by $47.5 million of asset sales and loan payoffs, which generated $830.1 million of net new investments.

9 Jul 2010

American, Canadian officials discuss global health developments at recent G8, G20 summits

The recent G8 summit in Canada's Muskoka region took an important step forward in improving maternal and child health in developing countries, Canadian and American officials said at a forum Wednesday in Washington, DC.

9 Jul 2010

BioCurex reports first set of results supporting RECAF blood test for monitoring cancer therapy

BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.

9 Jul 2010

Bayer HealthCare to present BAY86-6150 rFVIIa Phase I clinical data at XXIX WFH International Congress

Phase I clinical data for BAY86-6150, a novel recombinant factor VIIa protein (rFVIIa) being developed by Bayer HealthCare, will be presented at the XXIX International Congress of the World Federation of Hemophilia (WFH) to be held in Buenos Aires, Argentina from Saturday, July 10-Wednesday, July 14.

9 Jul 2010

Lawmakers, pundits offer mixed reaction to Berwick appointment

Politicians and pundits are reacting to President Barack Obama's recess appointment of Dr. Donald Berwick to run Medicare and Medicaid, with some saying such an appointment bypasses an important process while others praise the move.

9 Jul 2010

Medical News

WaferGen Biosystems announces closing of $7.2M registered direct offering

U.N. report recommends changes for fragmented global aid system

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

FDA approves Roxane's Naratriptan Tablets ANDA

Woman sues California Blue Shield for alleged safety-net insurance overcharges

Roxane announces FDA approval for Anastrozole Tablets ANDA

VBA acquires BISNet software from ClearBenefits

Medicare agency releases data on hospital performance

iPierian announces closing of $22M Series B equity financing round

Qualaquin for treatment of night time leg cramps leads to serious side effects, FDA warns

Officials look to stop 'medicalization' to stem health care costs

Psychosocial risk factors in children can be identified during transition from preschool to formal schooling

ITelagen to provide EHR, outsourced billing and IT support for Canterbury Medical Associates

Hospitals struggle to escape unsuccessful Wall Street wagers

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

Health Care REIT reports $292.9M of gross investments during second-quarter 2010

American, Canadian officials discuss global health developments at recent G8, G20 summits

BioCurex reports first set of results supporting RECAF blood test for monitoring cancer therapy

Bayer HealthCare to present BAY86-6150 rFVIIa Phase I clinical data at XXIX WFH International Congress

Lawmakers, pundits offer mixed reaction to Berwick appointment

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News